# Evaluation of Safety and Exploratory Efficacy of CARTISTEM®, a Cell Therapy Product for Articular Cartilage Defects

> **NCT01733186** · PHASE1,PHASE2 · COMPLETED · sponsor: **Medipost, Inc.** · enrollment: 12 (actual)

## Conditions studied

- Degeneration Articular Cartilage Knee

## Interventions

- **BIOLOGICAL:** CARTISTEM®

## Key facts

- **NCT ID:** NCT01733186
- **Lead sponsor:** Medipost, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-01-07
- **Primary completion:** 2017-06-02
- **Final completion:** 2017-08-29
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2026-01-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01733186

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01733186, "Evaluation of Safety and Exploratory Efficacy of CARTISTEM®, a Cell Therapy Product for Articular Cartilage Defects". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01733186. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*